Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 61, Issue 4, Pages 1392-1405
Publisher
Wiley
Online
2014-12-30
DOI
10.1002/hep.27678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 518 Changes in Serum Cytokeratin 18 Levels Significantly Predict Changes in Liver Histology in Adults With Nonalcoholic Steatohepatitis: Results From the Pivens Trial
- (2015) Raj Vuppalanchi et al. GASTROENTEROLOGY
- Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization
- (2014) Kavish R Patidar et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2013) Maria Stepanova et al. DIGESTIVE DISEASES AND SCIENCES
- Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2013) Paul Angulo et al. GASTROENTEROLOGY
- Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis
- (2013) Ja Kyung Koo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
- (2012) Donghee Kim et al. HEPATOLOGY
- The Framingham risk score and heart disease in nonalcoholic fatty liver disease
- (2012) Sombat Treeprasertsuk et al. LIVER INTERNATIONAL
- Prognostic indicators of survival in patients with compensated and decompensated cirrhosis
- (2012) Alexander Zipprich et al. LIVER INTERNATIONAL
- The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers
- (2011) Jasmohan S Bajaj et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
- (2011) Neeraj Bhala et al. HEPATOLOGY
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- Comparison of balloon vs. straight catheter for the measurement of portal hypertension
- (2010) A. Zipprich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Metabolic Syndrome and Liver Histology Among Children With Nonalcoholic Fatty Liver Disease
- (2010) Heather M Patton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
- (2010) Leon A Adams et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor
- (2010) D. L. H. Smith et al. CARCINOGENESIS
- Population-based risk factors and resource utilization for HCC: US perspective
- (2010) A. Sanyal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease
- (2010) Brent A. Neuschwander-Tetri et al. HEPATOLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients
- (2010) M. Sánchez-Conde et al. JOURNAL OF VIRAL HEPATITIS
- Pathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M. Brunt Nature Reviews Gastroenterology & Hepatology
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?
- (2010) Mohamed H. Ahmed et al. Primary Care Diabetes
- Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease
- (2009) K. D. KISTLER et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Identification of farnesoid X receptor modulators by a fluorescence polarization-based interaction assay
- (2009) Ki-Cheol Han et al. ANALYTICAL BIOCHEMISTRY
- Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
- (2009) Jonathan Y. Bass et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting Farnesoid-X-Receptor: From Medicinal Chemistry to Disease Treatment
- (2009) S. Fiorucci et al. CURRENT MEDICINAL CHEMISTRY
- Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network
- (2009) Kristin David et al. HEPATOLOGY
- Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
- (2009) Cristina Ripoll et al. JOURNAL OF HEPATOLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Trends in Nonalcoholic Fatty Liver Disease–related Hospitalizations in US Children, Adolescents, and Young Adults
- (2009) Corinna Koebnick et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Pediatric Nonalcoholic Fatty Liver Disease in 2009
- (2009) Anna Alisi et al. JOURNAL OF PEDIATRICS
- Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation
- (2009) Barbara Renga et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
- (2008) Winston Dunn et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
- (2008) Nila Rafiq et al. Clinical Gastroenterology and Hepatology
- Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis
- (2008) Heather M. Patton et al. GASTROENTEROLOGY
- Assessment of Prognosis of Cirrhosis
- (2008) François Durand et al. SEMINARS IN LIVER DISEASE
- Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation
- (2007) Sebastian E. Baumeister et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started